Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
2(25%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
1
13%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

2

trials recruiting

Total Trials

8

all time

Status Distribution
Active(2)
Completed(4)
Terminated(1)
Other(1)

Detailed Status

Completed4
Recruiting2
Withdrawn1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
2
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A1 (100.0%)

Trials by Status

withdrawn113%
recruiting225%
unknown113%
completed450%

Recent Activity

2 active trials
Showing 5 of 8
completed

The Effects of Anthracycline-based Chemotherapy on Peripheral Vascular Function

NCT03062878
completed

Characterisation of the Immune Response to SARS-CoV-2 Infection / COVID-19 in Type 1 Diabetes

NCT05171998
recruiting

CERvical Cancer The InFlammatory Index (CERTIFIKO)

NCT05673252
recruiting

Inflammatory Index as a Predictor for Endometrial Cancer: an Observational Study

NCT05657483
withdrawn

A Suspected Association Between Sarcoidosis and Development of Diabetes Mellitus

NCT03805633
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT03062878

The Effects of Anthracycline-based Chemotherapy on Peripheral Vascular Function

Completed
NCT05171998

Characterisation of the Immune Response to SARS-CoV-2 Infection / COVID-19 in Type 1 Diabetes

Completed
NCT05673252

CERvical Cancer The InFlammatory Index (CERTIFIKO)

Recruiting
NCT05657483

Inflammatory Index as a Predictor for Endometrial Cancer: an Observational Study

Recruiting
NCT03805633

A Suspected Association Between Sarcoidosis and Development of Diabetes Mellitus

Withdrawn
NCT02024113

LC-NMR Study Biomarkers to Detect Lung Cancer

Completed
NCT02362776

Metabolic Changes as a Diagnostic Indicator for Cancer

Completed
NCT00947492Not Applicable

Monitoring Epstein-Barr Virus (EBV) Load in Rheumatoid Arthritis Patients Treated With New Immunosuppressive Drugs

Unknown

All 8 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
8